Richard Resnick, CEO of Cureatr and former CEO of GQ Life Sciences, acquired by Aptean, explains his perspectives on human error in care delivery and how it spurred the idea for his latest company, Cureatr, that offers tech-enabled medication management to reduce readmissions into hospitals. He also describes the challenges unique to selling software into health systems and his thoughts on value-based care.